These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 21157970)
1. A new framework for reverse cholesterol transport: non-biliary contributions to reverse cholesterol transport. Temel RE; Brown JM World J Gastroenterol; 2010 Dec; 16(47):5946-52. PubMed ID: 21157970 [TBL] [Abstract][Full Text] [Related]
2. Biliary sterol secretion is required for functional in vivo reverse cholesterol transport in mice. Nijstad N; Gautier T; Briand F; Rader DJ; Tietge UJ Gastroenterology; 2011 Mar; 140(3):1043-51. PubMed ID: 21134376 [TBL] [Abstract][Full Text] [Related]
3. Biliary sterol secretion is not required for macrophage reverse cholesterol transport. Temel RE; Sawyer JK; Yu L; Lord C; Degirolamo C; McDaniel A; Marshall S; Wang N; Shah R; Rudel LL; Brown JM Cell Metab; 2010 Jul; 12(1):96-102. PubMed ID: 20620999 [TBL] [Abstract][Full Text] [Related]
4. A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion. Temel RE; Brown JM Trends Pharmacol Sci; 2015 Jul; 36(7):440-51. PubMed ID: 25930707 [TBL] [Abstract][Full Text] [Related]
5. From blood to gut: direct secretion of cholesterol via transintestinal cholesterol efflux. Vrins CL World J Gastroenterol; 2010 Dec; 16(47):5953-7. PubMed ID: 21157971 [TBL] [Abstract][Full Text] [Related]
6. Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss. Brown JM; Bell TA; Alger HM; Sawyer JK; Smith TL; Kelley K; Shah R; Wilson MD; Davis MA; Lee RG; Graham MJ; Crooke RM; Rudel LL J Biol Chem; 2008 Apr; 283(16):10522-34. PubMed ID: 18281279 [TBL] [Abstract][Full Text] [Related]
7. Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice. Kruit JK; Plösch T; Havinga R; Boverhof R; Groot PH; Groen AK; Kuipers F Gastroenterology; 2005 Jan; 128(1):147-56. PubMed ID: 15633131 [TBL] [Abstract][Full Text] [Related]
8. Biliary and nonbiliary contributions to reverse cholesterol transport. Temel RE; Brown JM Curr Opin Lipidol; 2012 Apr; 23(2):85-90. PubMed ID: 22262055 [TBL] [Abstract][Full Text] [Related]
9. Reverse cholesterol transport revisited: contribution of biliary versus intestinal cholesterol excretion. Brufau G; Groen AK; Kuipers F Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1726-33. PubMed ID: 21571685 [TBL] [Abstract][Full Text] [Related]
10. [Research advances of the biliary and nonbiliary pathways to reverse cholesterol transport]. Wang JL; Tang YY; Wu J; Tang CK Sheng Li Ke Xue Jin Zhan; 2013 Apr; 44(2):105-10. PubMed ID: 23847920 [TBL] [Abstract][Full Text] [Related]
11. Scavenger receptor BI and ABCG5/G8 differentially impact biliary sterol secretion and reverse cholesterol transport in mice. Dikkers A; Freak de Boer J; Annema W; Groen AK; Tietge UJ Hepatology; 2013 Jul; 58(1):293-303. PubMed ID: 23401258 [TBL] [Abstract][Full Text] [Related]
12. The combination of ezetimibe and ursodiol promotes fecal sterol excretion and reveals a G5G8-independent pathway for cholesterol elimination. Wang Y; Liu X; Pijut SS; Li J; Horn J; Bradford EM; Leggas M; Barrett TA; Graf GA J Lipid Res; 2015 Apr; 56(4):810-20. PubMed ID: 25635125 [TBL] [Abstract][Full Text] [Related]
13. Delineation of a novel hepatic route for the selective transfer of unesterified sterols from high-density lipoproteins to bile: studies using the perfused rat liver. Robins SJ; Fasulo JM Hepatology; 1999 May; 29(5):1541-8. PubMed ID: 10216140 [TBL] [Abstract][Full Text] [Related]
14. Hepatic ABCG5 and ABCG8 overexpression increases hepatobiliary sterol transport but does not alter aortic atherosclerosis in transgenic mice. Wu JE; Basso F; Shamburek RD; Amar MJ; Vaisman B; Szakacs G; Joyce C; Tansey T; Freeman L; Paigen BJ; Thomas F; Brewer HB; Santamarina-Fojo S J Biol Chem; 2004 May; 279(22):22913-25. PubMed ID: 15044450 [TBL] [Abstract][Full Text] [Related]
15. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Lewis GF; Rader DJ Circ Res; 2005 Jun; 96(12):1221-32. PubMed ID: 15976321 [TBL] [Abstract][Full Text] [Related]
16. Secretory phospholipase A2 increases SR-BI-mediated selective uptake from HDL but not biliary cholesterol secretion. Tietge UJ; Nijstad N; Havinga R; Baller JF; van der Sluijs FH; Bloks VW; Gautier T; Kuipers F J Lipid Res; 2008 Mar; 49(3):563-71. PubMed ID: 18037706 [TBL] [Abstract][Full Text] [Related]
18. Direct intestinal cholesterol secretion contributes significantly to total fecal neutral sterol excretion in mice. van der Velde AE; Vrins CL; van den Oever K; Kunne C; Oude Elferink RP; Kuipers F; Groen AK Gastroenterology; 2007 Sep; 133(3):967-75. PubMed ID: 17854600 [TBL] [Abstract][Full Text] [Related]
19. Hepatic ABCG5/G8 overexpression substantially increases biliary cholesterol secretion but does not impact in vivo macrophage-to-feces RCT. Dikkers A; de Boer JF; Groen AK; Tietge UJ Atherosclerosis; 2015 Dec; 243(2):402-6. PubMed ID: 26520893 [TBL] [Abstract][Full Text] [Related]
20. Intravenous apoA-I/lecithin discs increase pre-beta-HDL concentration in tissue fluid and stimulate reverse cholesterol transport in humans. Nanjee MN; Cooke CJ; Garvin R; Semeria F; Lewis G; Olszewski WL; Miller NE J Lipid Res; 2001 Oct; 42(10):1586-93. PubMed ID: 11590214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]